April 17, 2021
Clinical Implications of Genetic Mutations in Myelodysplastic Syndromes
Clinical Implications of Genetic Mutations in Myelodysplastic Syndromes
This webinar will provide an overview of recent advances in the genetic understanding of MDS, with a particular focus on the emerging role for mutational data in clinical management as a potential tool to assist in diagnosis, risk stratification, and therapeutic decision-making.
Speaker
RK
Rami Komrokji, MD
Our Supporters
Thank you to Bristol-Myers Squibb, Novartis, Jazz Pharmaceuticals, Takeda Oncology, Acceleron, and Gamida Cell for supporting this initiative.
